A monoclonal antibody against staphylococcal enterotoxin B superantigen inhibits SARS-CoV-2 entry in vitro

2021/04/29 by Mary Hongying Cheng, Rebecca A. Porritt, Magali Noval Rivas +9 · 1 voice
Medicine · #COVID-19 Clinical Research Studies #SARS-CoV-2 and COVID-19 Research #Viral Infections and Immunology Research

paper · pdf · doi:10.1016/j.str.2021.04.005

openalex publication_date 2021/04/29 · crossref created 2021/04/29 · crossref issued 2021/09/01 · crossref published 2021/09/01 · crossref published-print 2021/09/01 · openalex created_date 2025/10/10 · crossref deposited 2025/10/19 · crossref indexed 2026/06/16 · openalex updated_date 2026/08/04

Citations

• Molecular Evolution of Human Coronavirus Genomes
• Cryo-EM structure of the 2019-nCoV spike in the prefusion conformation
• Structure, Function, and Antigenicity of the SARS-CoV-2 Spike Glycoprotein
• SARS-CoV-2 Cell Entry Depends on ACE2 and TMPRSS2 and Is Blocked by a Clinically Proven Protease Inhibitor
• Structural basis for the recognition of SARS-CoV-2 by full-length human ACE2
• The proximal origin of SARS-CoV-2
• The trinity of COVID-19: immunity, inflammation and intervention
• Cell entry mechanisms of SARS-CoV-2
• Targets of T Cell Responses to SARS-CoV-2 Coronavirus in Humans with COVID-19 Disease and Unexposed Individuals
• Extrapulmonary manifestations of COVID-19
• Neuropilin-1 facilitates SARS-CoV-2 cell entry and infectivity
• Neuropilin-1 is a host factor for SARS-CoV-2 infection

Cited by

• Super(antigen) target for SARS-CoV-2

Discussions

• Cheng et al ‘A Monoclonal Antibody against Staphylococcal Enterotoxin B Superantigen Inhibits SARS-CoV-2 Entry in Vitro’. Structure (London, England : 1993), 29 April 2021. https://doi.org/10.1016/j.s [bsky, 0 points, 1 comments]